2760
F. Xiao et al. / Tetrahedron 64 (2008) 2755e2761
(75 MHz, CDCl3) d 20.39, 21.79, 122.59, 124.30, 125.15,
125.93, 128.24, 128.35, 128.53, 129.53, 129.70, 130.80, 131.63,
135.99, 136.31, 138.34, 140.68, 146.96, 147.66, 158.85; EIMS
(m/z, relative intensity): 309 (Mþ, 72), 308 (100), 292 (6), 232
(76), 217 (9); HRMS calcd for C23H19N: 309.1518; found:
309.1529.
4.4.13. 2-(3-Methoxyphenyl)-4-phenylquinoline (5i)
IR(film):701,770, 1044, 1209,1357, 1431, 1489, 1547,1589,
1
3060; H NMR (300 MHz, CDCl3) d 3.91 (s, 3H), 7.00 (dd,
J¼2.4, 8.1 Hz, 1H), 7.38e7.84 (m, 7H), 7.68e7.74 (m, 3H),
7.80 (s, 1H), 7.89 (d, J¼8.1 Hz, 1H), 8.24 (d, J¼8.1 Hz, 1H);
13C NMR (75 MHz, CDCl3) d 55.36, 112.63, 115.41, 119.37,
119.98, 125.58, 125.80, 126.31, 128.36, 128.54, 129.45, 129.52,
129.75, 130.10, 138.34, 141.09, 148.71, 149.07, 156.60, 160.10;
EIMS (m/z, relative intensity): 311 (Mþ, 75), 310 (100), 281(35),
267(7),241(3),204(9), 176(3),156(7),140(6), 133(8),121(5),
105(2);HRMScalcdfor C22H17ON: 311.1310;found:311.1312.
4.4.9. 2-(3-Bromophenyl)-4-phenylquinoline (5g)
IR (film): 701, 773, 793, 878, 1073, 1545, 1588, 3062; H
1
NMR (300 MHz, CDCl3) d 7.36 (t, J¼7.8 Hz, 1H), 7.44e7.58
(m, 7H), 7.70e7.73 (s, 1H), 7.75 (s, 1H), 7.90 (dd, J¼0.75,
8.11 Hz, 1H), 8.09 (dt, J¼0.72, 7.8 Hz, 1H), 8.21e8.24 (m,
1H), 8.38 (t, J¼1.7 Hz, 1H); 13C NMR (75 MHz, CDCl3) d
118.95, 123.09, 125.63, 125.87, 126.01, 126.65, 128.48, 128.60,
129.49, 129.69, 130.11, 130.27, 130.56, 132.18, 138.11, 141.57,
148.67, 149.42, 155.06; EIMS (m/z, relative intensity): 360
[(Mþ1)þ, 100], 359 (Mþ, 93), 278 (36), 252 (6), 176 (13),
151 (7), 139 (26); HRMS calcd for C21H14N79Br: 359.0310;
found: 359.0300.
4.4.14. 2-(4-Bromophenyl)-4-phenylquinoline (5j)
IR (film): 702, 772, 829, 1009, 1071, 1357, 1417, 1487, 1543,
1589; 1H NMR (300 MHz, CDCl3) d 7.44e7.76 (m, 10H), 7.89
(d, J¼8.1 Hz, 1H), 8.07 (d, J¼8.7 Hz, 2H), 8.21 (d, J¼8.4 Hz,
1H); 13C NMR (75 MHz, CDCl3) d 118.80, 123.91, 125.65,
125.78, 126.53, 128.47, 128.60, 129.05, 129.49, 129.67, 130.04,
131.91, 138.17, 138.41, 148.71, 149.37, 155.49; EIMS (m/z, rel-
ative intensity): 361 (91), 359 (Mþ, 100), 278 (27), 261 (23), 202
(14), 181 (5), 169 (37), 139 (20); HRMS calcd for C21H14N79Br
359.0310; found: 359.0302.
4.4.10. N-[1-(3-Bromophenyl)-3-phenylprop-2-ynyl]-4-
methylbenzenamine (4h)
1
IR (film): 690, 756, 788, 807, 1518, 1616, 3020; H NMR
(300 MHz, CDCl3) d 2.24 (s, 3H), 4.03 (d, J¼6.4 Hz, 1H), 5.41
(d, J¼6.4 Hz, 1H), 7.01 (dd, J¼0.6, 8.4 Hz, 1H), 7.21e7.30
(m, 4H), 7.38e7.46 (m, 3H), 7.54e7.58 (m, 1H), 7.80 (t,
J¼1.8 Hz, 1H); 13C NMR (75 MHz, CDCl3) d 20.44, 50.45,
85.40, 87.85, 114.30, 122.45, 122.74, 125.83, 128.11, 128.22,
129.68, 130.24, 130.28, 131.06, 131.73, 142.25, 143.88; EIMS
(m/z, relative intensity): 375 (Mþ, 16), 368 (3), 269 (100), 220
(22), 189 (38), 163 (3), 139 (2); HRMS calcd for C22H18N79Br:
375.0623; found: 375.0621.
4.4.15. 2-(4-Phenyphenyl)-4-phenylquinoline (5l)
IR (film): 699, 721, 731, 769, 847, 1007, 1358, 1415, 1445,
1
1487, 1542, 1589; H NMR (300 MHz, CDCl3) d 7.34e7.55
(m, 9H), 7.66e7.75 (m, 5H), 7.76e7.91 (m, 2H), 8.24e8.29
(m, 3H); 13C NMR (75 MHz, CDCl3) d 119.18, 125.62,
125.76, 126.30, 127.11, 127.50, 127.54, 127.93, 128.38, 128.57,
128.80, 129.53, 129.54, 130.09, 138.36, 138.45, 140.53, 142.02,
148.82, 149.11, 156.35; EIMS (m/z, relative intensity): 357
(Mþ, 100), 280 (3), 202 (14), 178 (10), 170 (2); HRMS calcd
for C27H19N: 357.1518; found: 357.1521.
4.4.11. 2-(3-Bromophenyl)-6-methyl-4-phenylquinoline (5h)
IR (film): 700, 765, 790, 825, 1491, 1546, 1587, 1714, 3058;
1H NMR (300 MHz, CDCl3) d 2.45 (s, 3H), 7.34 (t, J¼7.8 Hz,
1H), 7.49e7.56 (m, 7H), 7.63 (s, 1H), 7.70 (s, 1H), 8.07 (d,
J¼8.4 Hz, 1H), 8.11 (d, J¼8.4 Hz, 1H), 8.36 (s, 1H); 13C
NMR (75 MHz, CDCl3) d 21.80, 118.98, 123.06, 124.35,
125.82, 125.88, 128.35, 128.57, 129.46, 129.83, 130.21, 130.44,
131.92, 131.97, 136.64, 138.34, 141.68, 147.26, 148.65, 154.15;
EIMS (m/z, relative intensity): 373 (Mþ, 100), 358 (38), 294
(23), 278 (16), 265 (2), 252 (2), 261 (10), 202 (5), 187 (3), 139
(24), 125 (6); HRMS calcd for C22H16N79Br: 373.0466; found:
373.0467.
4.4.16. N-[3-(Naphthalen-1-yl)-1-phenylprop-2-ynyl]
benzenamine (4m)
1
IR (film): 696, 749, 774, 799, 1501, 1601, 3054, 3401; H
NMR (200 MHz, CDCl3) d 4.30 (br, 1H), 5.54 (s, 1H), 5.67e
6.89 (m, 3H), 7.19e7.50 (m, 8H), 7.61e7.92 (m, 5H), 8.06e
8.12 (m, 1H); 13C NMR (50 MHz, CDCl3) d 51.20, 83.40,
93.34, 114.66, 118.99, 120.42, 125.07, 126.18, 126.31, 126.75,
127.47, 128.16, 128.20, 128.76, 128.84, 129.22, 130.49, 133.10,
133.39, 139.56, 146.50; EIMS (m/z, relative intensity): 333
(Mþ, 7), 241 (100), 149 (3), 77 (2); HRMS calcd for
C25H19N: 333.1518; found: 333.1513.
4.4.12. N-[1-(3-Methoxyphenyl)-3-phenylprop-2-ynyl]
benzenamine (4i)
4.4.17. 4-(Naphthalen-1-yl)-2-phenylquinoline (5m)
IR (film): 690, 754, 787, 871, 1046, 1154, 1255, 1433, 1489,
1501, 1600, 2924; 1H NMR (300 MHz, CDCl3) d 3.80 (s, 3H),
4.14 (br, 1H), 5.46 (s, 1H), 6.75e7.42 (m, 14H); 13C NMR
(75 MHz, CDCl3) d 50.60, 55.24, 84.96, 88.34, 112.86,
113.53, 114.04, 118.56, 119.53, 122.71, 128.18, 128.27,
129.13, 129.77, 131.71, 141.29, 146.48, 159.90; EIMS (m/z,
relative intensity): 313 (Mþ, 9), 221 (100), 211 (45), 178 (14),
167 (6); HRMS calcd for C22H19ON: 313.1467; found:
313.1469.
IR (film): 694, 731, 770, 804, 908, 1396, 1547, 1590, 3381;
1H NMR (300 MHz, CDCl3) d 7.29e7.73 (m, 11H), 7.91e
8.00 (m, 3H), 8.19e8.22 (m, 2H), 8.30 (d, J¼8.4 Hz, 1H); 13
C
NMR (75 MHz, CDCl3) d 120.47, 125.27, 125.96, 126.12,
126.16, 126.34, 126.48, 127.00, 127.38, 127.62, 128.30, 128.76,
128.84, 129.43, 129.71, 129.87, 131.92, 133.47, 135.89, 139.36,
148.11, 148.35, 156.78; EIMS (m/z, relative intensity): 331
(Mþ, 100), 252 (16), 226 (10), 164 (14); HRMS calcd for
C25H17N: 331.1361; found: 331.1367.